Created by potrace 1.16, written by Peter Selinger 2001-2019beatandraise.com
Latest Financials

Filings:

CategoryDateSearch FilingsInstitutional HoldersbetaEarnings TranscriptsbetaGlobal Search

SEC Edgar

SANGAMO THERAPEUTICS, INC

SIC 2836 · Biological Products (No Diagnostic Substances)
NotesSupport
aboutterms
$SGMOQ

SANGAMO THERAPEUTICS, INC

CIK:0001001233|SEC Filings

MATERIAL CONTRACTS

EX-10.1
sgmo-20250930xex101.htm
Nov 6, 2025
EX-10.2
sgmo-20250930xex102.htm
Nov 6, 2025
EX-10.3
sgmo-20250930xex103.htm
Nov 6, 2025
EX-10.1
ex-101amendedandrestated20.htm
Jun 16, 2025
EX-10.1
sgmo-20240930xex101.htm
Nov 12, 2024
EX-10.2
thirdamendmenttoleaseagr.htm
Nov 12, 2024
EX-10.1
ex-101amendedandrestated.htm
Jun 5, 2024
EX-10.1
secondamendmenttoleaseag.htm
May 9, 2024
EX-10.1
d816036dex101.htm
Mar 25, 2024
EX-10.2
d816036dex102.htm
Mar 25, 2024
EX-10.24
exhibit1024incentivecomp.htm
Mar 13, 2024
EX-10.35
exhibit1035sangamo-2024c.htm
Mar 13, 2024
EX-10.36
exhibit1036sangamo-2024c.htm
Mar 13, 2024
EX-10.1
sangamoexecutiveseveranc.htm
Nov 1, 2023
EX-10.1
sgmo2018eiparmarch2023.htm
Jun 2, 2023
EX-10.53
exhibit1053-pfizersb525l.htm
Feb 23, 2023
EX-10.1
sgmo-20220930xex101_employ.htm
Nov 3, 2022
EX-10.1
exhibit101-amendedandresta.htm
May 25, 2022
EX-10.34
sgmo-20211231xex1034_emplo.htm
Feb 24, 2022
EX-10.45
sgmo-20211231xex1045_ame.htm
Feb 24, 2022